Distinguished in Ulcerative Colitis

Nikos Viazis

Athens, ESYE31, GR 
Distinguished in Ulcerative Colitis
Athens, ESYE31, GR 
OverviewLocationsClinical Research

Overview

Nikos Viazis practices in Athens, Greece. Mr. Viazis is rated as a Distinguished expert by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Colitis, Viral Gastroenteritis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 58 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles in the study of Ulcerative Colitis.

Gender
Male

Locations

Athens, ESYE31, Greece
Other Locations
Attiki, ESYE31 10676, Greece
Rio, ESYE23, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Cold Snare Polypectomy vs Hot Snare Polypectomy vs APC for the Complete Removal of Left Sided Colon Polyps. A Prospective,Randomized Trial
Cold Snare Polypectomy vs Hot Snare Polypectomy vs APC for the Complete Removal of Left Sided Colon Polyps. A Prospective,Randomized Trial
Enrollment Status: Completed
Publish Date: May 11, 2020
Intervention Type: Procedure
Proton Pump Inhibitor (PPI's) and Selective Serotonin Reuptake Inhibitor Therapy (SSRI's) for the Management of Non Cardiac Chest Pain (NCCP)
Proton Pump Inhibitor (PPI's) and Selective Serotonin Reuptake Inhibitor Therapy (SSRI's) for the Management of Non Cardiac Chest Pain (NCCP)
Enrollment Status: Terminated
Publish Date: December 02, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

58 Total Publications

Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.
Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.
Journal: Frontiers in medicine
Published: February 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Viazis's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile